IGM Biosciences Inc
(NAS:IGMS)
$
17.25
-0.57 (-3.2%)
Market Cap: 1.02 Bil
Enterprise Value: 840.64 Mil
PE Ratio: 0
PB Ratio: 8.34
GF Score: 30/100 
IGM Biosciences Inc at Jefferies Virtual London Healthcare Conference Transcript
Nov 17, 2020 / 07:20PM GMT
Release Date Price:
$53.77
(-0.43%)
Biren N. Amin
Jefferies LLC, Research Division - MD and Senior Equity Research Analyst
Welcome, everyone, to the Jefferies London Virtual Health Care Conference. My name is Biren Amin. I'm one of the biotech analysts here at Jefferies. And I'd like to welcome our next company, IGM Biosciences and their CEO, Fred Schwartzer. So welcome, Fred, for participating in this fireside.
Fred M. Schwarzer
IGM Biosciences, Inc. - CEO, President & Director
Thanks very much. Really appreciate the opportunity.
Questions & Answers
Biren N. Amin
Jefferies LLC, Research Division - MD and Senior Equity Research Analyst
So maybe to start off for those that aren't not familiar with IGM. You have a unique monoclonal antibody platform in researching and developing IGM, format monoclonal antibodies. Maybe just talk about this platform relative to the IgG peers.
Fred M. Schwarzer
IGM Biosciences, Inc. - CEO, President & Director
Sure. That's my pleasure. Well, let me step
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers